Apart from lowering LDL-C and by this, preventing the progression of atherosclerosis, possible direct effects of PCSK9 on atherosclerosis and its involvement in inflammation, triglyceride-rich lipoprotein metabolism, platelet activation, cancer, and viral infections have been described [12,13]. The gene discussed is PCSK9; the disease is atherosclerosis.